Charité - Universitätsmedizin Berlin

Metabolic and molecular imaging in inflammatory arthritis (2024) Noversa de Sousa R, Tascilar K, Corte G, Atzinger A, Minopoulou I, Ohrndorf S, Waldner M, et al. Journal article, Review article Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort study (2024) Beer BN, Kellner C, Goßling A, Sundermeyer J, Besch L, Dettling A, Kirchhof P, et al. Journal article SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency (2024) Zhang L, Kempf A, Nehlmeier I, Cossmann A, Richter A, Bdeir N, Graichen L, et al. Journal article Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer (2024) Fasching P, Decker T, Hartkopf A, Nusch A, Heinrich BJ, Kurbacher C, Fuchs R, et al. Journal article Dermatologist-like explainable AI enhances trust and confidence in diagnosing melanoma (2024) Brinker TJ, Chanda T, Hauser K, Hobelsberger S, Bucher TC, Garcia CN, Wies C, et al. Journal article Cortical matrix remodeling as a hallmark of relapsing–remitting neuroinflammation in MR elastography and quantitative MRI (2024) Silva RV, Morr AS, Herthum H, Koch SP, Mueller S, Batzdorf CS, Bertalan G, et al. Journal article Diskriminierung im Medizinstudium zweier Universitäten (2024) Zoellick JC, Dettmer S, Voss A Conference contribution, Conference Contribution Diskriminierungserfahrungen im Medizinstudium (2024) Zoellick JC, Voss A Conference contribution, Conference Contribution Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024. (2024) Park-Simon TW, Müller V, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, et al. Journal article, Review article Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients. (2024) Massa C, Karn T, Weber KE, Schneeweiss A, Hanusch C, Blohmer JU, Zahm DM, et al. Journal article, Letter